Plant · Scientific monograph
Azadirachta indica
Neem
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Metabolic research, Traditional use
Research overview
Historical use
Neem has a long history in traditional South Asian systems; uses vary by plant part and preparation. The clinical study cited here evaluates only a standardized aqueous leaf-and-twig extract [1].
Modern research context
A placebo-controlled study examined a standardized aqueous neem leaf-and-twig extract as an adjunct to metformin in people with type 2 diabetes. This single-product study cannot establish efficacy for neem generally, other parts, or use without standard care [1].
Adverse effects
The RCT's duration and size do not establish uncommon or long-term harms. Animal toxicity literature is not confirmation of human safety [1,2].
Contraindications
Do not generalize from this extract to neem oil, seed, bark or other products. Human interaction evidence is insufficient; medicinal use in diabetes requires particular caution because the trial involved concurrent metformin [1].
Clinical and phytochemical data
Used part
Standardized aqueous leaf-and-twig extract in the RCT; other neem products are not interchangeable [1].
Primary active compounds
Mechanism of action
The human trial reports metabolic and vascular endpoints but does not establish a mechanism applicable to all neem preparations [1]. The cited human studies do not characterize an active compound or establish constituent-specific activity.
Pharmacokinetics
Absorption
No human PK data for the tested formulation are reported in the abstract [1].
Distribution
Not characterized.
Metabolism
Not characterized.
Excretion
Not characterized.
Safety and interactions
Drug interactions
A clinical interaction with metformin was not isolated; the trial studied adjunctive use [1].
Toxicity
Human long-term toxicity is not adequately characterized; animal toxicity findings cannot be directly extrapolated [2].
Special precautions
Pregnancy
Pregnancy safety for medicinal neem products is not established in the cited human evidence.
Lactation
Lactation safety is not established.
Hepatic impairment
No human evidence sufficient to characterize hepatic impairment.
Renal impairment
No human evidence sufficient to characterize renal impairment.
Sources and references
- [1] Pingali U et al. Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity. 2020;13:4401-4412. PMID: 33244247. DOI: 10.2147/DMSO.S274378.
- [2] Teresa M. Braga et al. Azadirachta indica A. Juss. In Vivo Toxicity—An Updated Review. Molecules. 2021;26(2):252. PMID: 33419112. DOI: 10.3390/molecules26020252.